Braxlosiran
Braxlosiran is a small nucleic acid targeting DUX4 (double homeobox protein), utilized in the synthesis of AOC drugs such as Delpacibart braxlosiran. Abnormal expression of the DUX4 protein leads to altered gene expression in muscle cells, which is associated with muscle function loss in facioscapulohumeral muscular dystrophy (FSHD) .
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882860-100 1x 100 µL
Mitochondria (Marker for Human Cells, Granular RCC's & Salivary Tumors) (MTC02/2860R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
